Purpose Investments Inc. Announces 2025 Final Annual Cash Distributions for Purpose Mutual Fund Trusts with December 15, 2025 Tax Year-End

Purpose Investments Inc. Announces 2025 Final Annual Cash Distributions for Purpose Mutual Fund Trusts with December 15, 2025 Tax Year-End GlobeNewswire December 19, 2025 TORONTO, Dec. 18, 2025 (GLOBE NEWSWIRE) — Purpose Investments Inc. (“Purpose”) today announced the final annual capital gain distributions for its open-end exchange-traded funds structured as mutual fund trusts (the “Funds”) […]

Early Warning Press Release Regarding Acquisition of Common Shares in Carbon Streaming Corporation by Marin Katusa

Early Warning Press Release Regarding Acquisition of Common Shares in Carbon Streaming Corporation by Marin Katusa GlobeNewswire December 19, 2025 TORONTO, Dec. 18, 2025 (GLOBE NEWSWIRE) — Carbon Streaming Corporation (Cboe CA: NETZ) (OTCQB: OFSTF) (FSE: M2Q) (the “Company“), reports that Mr. Marin Katusa (the “Acquiror“), the Chief Executive Officer of the Company, has purchased

FEX Announces Board Transition and Appointment of Sean Davis

Vancouver, British Columbia–(Newsfile Corp. – December 18, 2025) – Fjordland Exploration Inc. (TSXV: FEX) (the "Company") is pleased to announce the appointment of Sean Davis to its Board of Directors, effective immediately. Sean Davis brings more than 20 years of senior management and board experience across public and private companies. He has served as a

SBS CyberSecurity Appoints CFO and Announces Sales Team Enhancements

SBS CyberSecurity, a leading and trusted governance, risk, and compliance (GRC) partner incybersecurity consulting, testing, and auditing, announced the appointment of Ben Goodman as chief financial officer, effective December 1, 2025. This strategic addition to the leadership team underscores SBS's commitment to operational excellence and positions the company for continued growth. https://mma.prnewswire.com/media/2777830/SBS_CyberSecurity_Logo.jpg Goodman brings more

Rezubio Announces $20 Million Series A Financing to Advance the Membrane-Anchored Therapeutics Platform and Company Pipeline, with Lead Program in Obesity and Diabetes

ZHUHAI, China, Dec. 18, 2025 (GLOBE NEWSWIRE) — Rezubio, a China-based biotechnology company founded by former Merck scientists, today announced the closing of a $20 million Series A financing. Proceeds will be used to advance the company's lead program into Phase 2 clinical development for obesity and diabetes, as well as other programs in IND-enabling

Rezubio Announces $20 Million Series A Financing to Advance the Membrane-Anchored Therapeutics Platform and Company Pipeline, with Lead Program in Obesity and Diabetes

Rezubio Announces $20 Million Series A Financing to Advance the Membrane-Anchored Therapeutics Platform and Company Pipeline, with Lead Program in Obesity and Diabetes GlobeNewswire December 19, 2025 ZHUHAI, China, Dec. 18, 2025 (GLOBE NEWSWIRE) — Rezubio, a China-based biotechnology company founded by former Merck scientists, today announced the closing of a $20 million Series A

Nova Minerals Announces Pricing of Public Offering

(NASDAQ:NVA),(NASDAQ:NVAWW),(OTC US:NVAAF),(Other OTC:NVAAF),(Boerse Frankfurt – Freiverkehr:QM3),(AUST:NVA.AX), Melbourne, Australia, Dec. 18, 2025 (GLOBE NEWSWIRE) — Nova Minerals Limited (“Nova” and the “Company“) (Nasdaq NVA, NVAWW) (ASX: NVA)(FRA: QM3)), a gold, antimony and critical minerals exploration stage company focused on advancing the Estelle Gold and Critical Minerals Project in Alaska, today announced the pricing of an underwritten

Nova Minerals Announces Pricing of Public Offering

Nova Minerals Announces Pricing of Public Offering GlobeNewswire December 19, 2025 Melbourne, Australia, Dec. 18, 2025 (GLOBE NEWSWIRE) — Nova Minerals Limited (“Nova” and the “Company“) (Nasdaq NVA, NVAWW) (ASX: NVA)(FRA: QM3)), a gold, antimony and critical minerals exploration stage company focused on advancing the Estelle Gold and Critical Minerals Project in Alaska, today announced

Synadentix Targets Oral Microbiome as Consumers Seek Solutions Beyond Brushing for Gum Health and Fresh Breath

AUSTIN, Dec. 18, 2025 (GLOBE NEWSWIRE) — The science of the oral microbiome has moved from academic journals into mainstream health conversations, prompting growing consumer interest in understanding how bacterial balance may influence dental wellness. Against this backdrop, products like Synadentix, a chewable dental health supplement, have entered the market with formulas designed to support

Synadentix Targets Oral Microbiome as Consumers Seek Solutions Beyond Brushing for Gum Health and Fresh Breath

Synadentix Targets Oral Microbiome as Consumers Seek Solutions Beyond Brushing for Gum Health and Fresh Breath Chewable nighttime formula featuring hydroxyapatite, lactoferrin, and enzyme complex enters dental supplement market amid rising interest in bacterial-balance approaches to oral care GlobeNewswire December 19, 2025 AUSTIN, Dec. 18, 2025 (GLOBE NEWSWIRE) — The science of the oral microbiome

Scroll to Top